All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
Pr Newswire

AI-Powered Retail Media Platform PulseAd Enters $280B US Market with Seattle...

admin
Pr Newswire

Football fans in the UK will be able to watch every...

admin
Pr Newswire

Football fans in the UK will be able to watch every...

admin
Pr Newswire

Football fans in the UK will be able to watch every...

admin
Pr Newswire

Supermicro Delivers Performance and Efficiency Optimized Liquid-Cooled and Air-Cooled AI Solutions...

admin
People

Aayush Wellness Bridging Ancient Ayurvedic Wisdom with Modern Wellness offering Aayush...

admin
People

North America Hair Care Market, Competition, and Forecasts 2025-2030: Rise of...

admin
People

Iterate.ai Raises $6.4 Million from Auxier Asset Management and eBags Board...

admin
Pr Newswire

Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension

admin
Pr Newswire

AIM ImmunoTech Announces NYSE American Removal of Trading Suspension

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...